C
Canwei Wang
Researcher at Wenzhou Medical College
Publications - 5
Citations - 173
Canwei Wang is an academic researcher from Wenzhou Medical College. The author has contributed to research in topics: Colorectal cancer & Cell growth. The author has an hindex of 3, co-authored 4 publications receiving 76 citations.
Papers
More filters
Journal ArticleDOI
miR-196b-5p–mediated downregulation of TSPAN12 and GATA6 promotes tumor progression in non-small cell lung cancer
Guang Liang,Wei Meng,Xiangjie Huang,Wangyu Zhu,Changtian Yin,Canwei Wang,Matteo Fassan,Yun Yu,Masahisa Kudo,Sisi Xiao,Chengguang Zhao,Peng Zou,Yumin Wang,Xiaokun Li,Carlo M. Croce,Ri Cui +15 more
TL;DR: The findings indicate that QKI-5 may exhibit novel anticancer mechanisms by regulating miRNA in NSCLC, and targeting the QKI5∼miR-196b-5p∼GATA6/TSPAN12 pathway may enable effectively treating some NSCLCs.
Journal ArticleDOI
Curcumin derivative WZ35 inhibits tumor cell growth via ROS-YAP-JNK signaling pathway in breast cancer
Lihua Wang,Canwei Wang,Tao Zheying,Liqian Zhao,Zheng Zhu,Wencan Wu,He Ye,Chen Hong,Zheng Bin,Xiangjie Huang,Yun Yu,Linjun Yang,Guang Liang,Ri Cui,Tongke Chen +14 more
TL;DR: Treatment of breast cancer cells with WZ35 exerts stronger anti-tumor activities than curcumin both in vitro and in vivo, and novel anti-cancer mechanisms of WZ34 and ROS-YAP-JNK pathway might be a potential therapeutic target for the treatment of breastcancer patients.
Journal ArticleDOI
Alantolactone promotes ER stress-mediated apoptosis by inhibition of TrxR1 in triple-negative breast cancer cell lines and in a mouse model.
Changtian Yin,Changtian Yin,Xuanxuan Dai,Xiangjie Huang,Wangyu Zhu,Xi Chen,Qiulin Zhou,Canwei Wang,Chengguang Zhao,Peng Zou,Guang Liang,Vinothkumar Rajamanickam,Ou-chen Wang,Xiaohua Zhang,Ri Cui +14 more
TL;DR: It is found that ATL suppresses TNBC cell viability by reactive oxygen species (ROS) accumulation and subsequent ROS‐dependent endoplasmic reticulum (ER) stress both in vitro and in vivo.
Journal ArticleDOI
Gracillin shows potent efficacy against colorectal cancer through inhibiting the STAT3 pathway.
Lehe Yang,Tianru Zhu,Hua Ye,Yili Shen,Zhiping Li,Luye Chen,Canwei Wang,Xia Chen,Haiyang Zhao,Youqun Xiang,Zhongxiang Xiao,Chengguang Zhao,Jifa Li,Wanle Hu +13 more
TL;DR: Gracillin shows potent efficacy against CRC by inhibiting the STAT3 pathway and should be further explored as a unique STAT3 inhibitor for the treatment of CRC.
Journal ArticleDOI
Dihydroartemisinin enhances the anti-tumor activity of oxaliplatin in colorectal cancer cells by altering PRDX2-reactive oxygen species-mediated multiple signaling pathways.
Yun Yu,Didi Chen,Tao Wu,Hai-Shu Lin,Lianli Ni,Hehuan Sui,Sisi Xiao,Canwei Wang,Su-cheng Jiang,Huan-Yu Pan,Shaotang Li,Xiance Jin,Congying Xie,Rihua Cui +13 more
TL;DR: In this article , an improved therapeutic strategy for colorectal cancer patients by combining DHA and oxaliplatin treatments was demonstrated. But, the direct target of DHA was not clarified and underlying molecular mechanisms in oxalplatin-mediated anti-tumor activities against CRC are unclear.